Melatonin Lulling Th17 Cells to Sleep.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26359982.
- Also identified by DOI 10.1016/j.cell.2015.08.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue, Farez et al. report that the circadian hormone melatonin, whose levels vary with seasonal changes in night length, shifts the immune response toward an anti-inflammatory state that may explain the seasonal variability of multiple sclerosis disease activity.
Medical subject headings
- Melatonin
- Multiple Sclerosis